Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C. A clinical update

S D Colquhoun1

  • 1Department of Surgery, University of California, Davis Medical Center, Sacramento, USA.

Archives of Surgery (Chicago, Ill. : 1960)
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intraoperative pulmonary embolism and intracardiac thrombosis complicating liver transplantation: a systematic review.

Journal of thrombosis and haemostasis : JTH·2007
Same author

Primary hepatic carcinoid tumor presenting as Cushing's syndrome.

Journal of endocrinological investigation·2007
Same author

Abdominal compartment syndrome secondary to retroperitoneal hematoma as a complication of ERCP after liver transplantation.

Transplantation proceedings·2007
Same author

Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2001
Same author

Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2001
Same author

Induction of peroxiredoxins in transplanted livers and demonstration of their in vitro cytoprotection activity.

Antioxidants & redox signaling·2001
Same journal

The White Test: A New Dye Test for Intraoperative Detection of Bile Leakage During Major Liver Resection-Invited Critique.

Archives of surgery (Chicago, Ill. : 1960)·2017
Same journal

Use of Vascular Clamping in Hepatic Surgery: Lessons Learned From 1260 Liver Resections-Invited Critique.

Archives of surgery (Chicago, Ill. : 1960)·2017
Same journal

Randomized Clinical Trial of Small-Incision and Laparoscopic Cholecystectomy in Patients With Symptomatic Cholecystolithiasis: Primary and Clinical Outcomes-Invited Critique.

Archives of surgery (Chicago, Ill. : 1960)·2017
Same journal

Liver Resection With a New Multiprobe Bipolar Radiofrequency Device-Invited Critique.

Archives of surgery (Chicago, Ill. : 1960)·2017
Same journal

Porcine and Bovine Surgical Products: Jewish, Muslim, and Hindu Perspectives-Invited Critique.

Archives of surgery (Chicago, Ill. : 1960)·2017
Same journal

Neuroendocrine Liver Metastasis: Transplant as Part of Multimodality Liver-Directed Therapy-Reply.

Archives of surgery (Chicago, Ill. : 1960)·2016
See all related articles

Hepatitis C virus causes most non-A, non-B hepatitis cases, often leading to chronic infections with severe outcomes. Prevention is currently the most effective strategy against this widespread liver disease.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) identified as the primary cause of non-A, non-B hepatitis.
  • Significant advancements in understanding HCV and its disease spectrum since its discovery.

Purpose of the Study:

  • To review current knowledge on Hepatitis C virus.
  • To discuss the implications of chronic HCV infections.
  • To evaluate existing and potential therapeutic strategies.

Main Methods:

  • Literature review of recent studies on Hepatitis C virus.
  • Analysis of epidemiological data on HCV infection rates.
  • Assessment of current treatment efficacy and future prospects.

Main Results:

Related Experiment Videos

  • HCV is responsible for over 90% of non-A, non-B hepatitis.
  • Nearly all HCV infections may progress to chronic disease.
  • Delayed but severe health consequences are associated with chronic HCV.

Conclusions:

  • Current Hepatitis C treatments are limited and unsatisfactory.
  • Development of an effective vaccine for HCV remains a long-term objective.
  • Preventive measures are the most effective approach for managing Hepatitis C virus currently.